Table 2.
Vaccine design scheme: epitope sequence arrangement of construct 1 and construct 2 (A: YQSTGNMSE, B: YTTSEGRDV, C: LKAHPKYPN, D: YRLSFKQSL, E: YNLNKKRFD, F: YTLSNARFR, G: LRQQLSKGS and L:GPGPG).
| Vaccine | Epitope arrangement | HADDOCK Refinement score |
|---|---|---|
| Construct 1 | ALC | − 77.4 ± 0.4 |
| ALCLF | − 74.2 ± 0.7 | |
| ALCLFLB | − 80.0 ± 0.4 | |
| ALCLFLBLE | − 86.5 ± 0.6 | |
| ALCLFLBLELD | − 86.2 ± 0.9 | |
| ALCLFLBLELDLG | − 74.8 ± 0.9 | |
| Construct 2 | ALC | − 77.4 ± 0.4 |
| ALCLF | − 74.2 ± 0.7 | |
| ALCLFLG | − 81.7 ± 1.1 | |
| ALCLFLGLD | − 83.8 ± 0.7 | |
| ALCLFLGLDLB | − 75.0 ± 1.4 | |
| ALCLFLGLDLBLE | − 88.8 ± 1.6 |